# Magnitude of Osteoarthritis disadVantage on pEoples liveS

> **NCT01423097** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1015 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01423097
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 1015 (ACTUAL)
- **Last updated:** 2012-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01423097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01423097, "Magnitude of Osteoarthritis disadVantage on pEoples liveS". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01423097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*